IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
Open Access
- 1 January 2017
- journal article
- Published by Elsevier in Cell Reports
- Vol. 18 (2) , 432-442
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5F32AI080099)
- Novartis Pharmaceuticals Corporation
This publication has 49 references indexed in Scilit:
- Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) IsoformsPLOS ONE, 2012
- The CBS Domain: A Protein Module with an Emerging Prominent Role in RegulationACS Chemical Biology, 2011
- The Cyclophilin-Binding Agent Sanglifehrin A Is a Dendritic Cell Chemokine and Migration InhibitorPLOS ONE, 2011
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- IMP Dehydrogenase: Structure, Mechanism, and InhibitionChemical Reviews, 2009
- A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide BiosynthesisJournal of Biological Chemistry, 2009
- IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNAJournal of Biological Chemistry, 2008
- The CBS subdomain of inosine 5′‐monophosphate dehydrogenase regulates purine nucleotide turnoverMolecular Microbiology, 2008
- CBS domains: structure, function, and pathology in human proteinsAmerican Journal of Physiology-Cell Physiology, 2005
- Myasthenia GravisNew England Journal of Medicine, 1994